TOPICAL WOUND HEALING MEDICAMENT CONTAINING

Brand Owner (click to sort) Address Description
CHRONSEAL KRINGLE PHARMA EUROPE AB HALSOVAGEN 7 HUDDINGE SE141 57 Sweden Topical wound healing medicament containing a recombinant skin growth factor protein for treatment purposes;
CHRONSEAL Kringle Pharma, Inc. 2F Saito Bio Incubator 7-7-15, Saitoasagi Ibaraki-shi, Osaka 567-0085 Japan Topical wound healing medicament containing a recombinant skin growth factor protein for treatment purposes;CHRONIC SEAL;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention provides methods and compositions useful in localized transfer of genetic material or proteins. Moreover, the present invention provides methods and compositions for improving and/or controlling wound healing by applying a wound care device comprising HoxD3 and/or HoxA3 and/or HoxB3. In addition, the present invention provides methods and compositions for improved wound healing in subjects having impaired healing capabilities, such as diabetic subjects.